P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activity

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 3, 2010, Pages 515-525

  Nervi, Pierluigi ^a   Li Blatter, Xiaochun ^a   Äänismaa, Päivi ^a   Seelig, Anna ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Active efflux; ATPase activity; Extracellular acidification rate; Influx; P glycoprotein substrate; Passive diffusion

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CYCLOSPORIN A; DAUNORUBICIN; DILTIAZEM; GLYCOPROTEIN P; VERAPAMIL;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL MEMBRANE; CELL SHAPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; GLYCOLYSIS; LIPID BILAYER; LIPID MEMBRANE; MEMBRANE LEAFLET; MEMBRANE VESICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ACIDS; ADENOSINE TRIPHOSPHATASES; AIR; ANIMALS; BIOLOGICAL TRANSPORT; CELL SURVIVAL; CYCLOSPORINE; DETERGENTS; EXTRACELLULAR SPACE; FIBROBLASTS; HUMANS; MICE; MICELLES; NIH 3T3 CELLS; P-GLYCOPROTEIN; PERMEABILITY; SUBSTRATE SPECIFICITY; TIME FACTORS; TRANSFECTION; TRANSPORT VESICLES; WATER;

EID: 76749084410     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.11.022     Document Type: Article

References (43)

1. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., and Gottesman M.M. Targeting multidrug resistance in cancer. Nat. Rev. 5 (2006) 219-234
2. Dey S., Ramachandra M., Pastan I., Gottesman M.M., and Ambudkar S.V. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10594-10599
3. Raviv Y., Pollard H.B., Bruggemann E.P., Pastan I., and Gottesman M.M. Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. J. Biol. Chem. 265 (1990) 3975-3980
4. Higgins C.F., and Gottesman M.M. Is the multidrug transporter a flippase?. Trends Biochem. Sci. 17 (1992) 18-21
5. Urbatsch I.L., Sankaran B., Bhagat S., and Senior A.E. Both P-glycoprotein nucleotide-binding sites are catalytically active. J. Biol. Chem. 270 (1995) 26956-26961
6. Ambudkar S.V., Cardarelli C.O., Pashinsky I., and Stein W.D. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein. J. Biol. Chem. 272 (1997) 21160-21166
7. Shapiro A.B., and Ling V. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein. Eur. J. Biochem. 254 (1998) 189-193
8. Stein W.D. Kinetics of the P-glycoprotein, the multidrug transporter. Exp. Physiol. 83 (1998) 221-232
9. Eytan G.D., Regev R., Oren G., and Assaraf Y.G. The role of passive transbilayer drug movement in multidrug resistance and its modulation. J. Biol. Chem. 271 (1996) 12897-12902
10. Hochman J.H., Yamazaki M., Ohe T., and Lin J.H. Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein. Curr. Drug. Metab. 3 (2002) 257-273
11. Omote H., and Al-Shawi M.K. A novel electron paramagnetic resonance approach to determine the mechanism of drug transport by P-glycoprotein. J. Biol. Chem. 277 (2002) 45688-45694
12. Seelig A., and Gatlik-Landwojtowicz E. Inhibitors of multidrug efflux transporters: their membrane and protein interactions. Mini. Rev. Med. Chem. 5 (2005) 135-151
13. Seelig A. The role of size and charge for blood-brain barrier permeation of drugs and fatty acids. J. Mol. Neurosci. 33 (2007) 32-41
14. Horio M., Pastan I., Gottesman M.M., and Handler J.S. Transepithelial transport of vinblastine by kidney-derived cell lines. Application of a new kinetic model to estimate in situ Km of the pump. Biochim. Biophys. Acta 1027 (1990) 116-122
15. Polli J.W., Wring S.A., Humphreys J.E., Huang L., Morgan J.B., Webster L.O., and Serabjit-Singh C.S. Rational use of in vitro P-glycoprotein assays in drug discovery. J. Pharmacol. Exp. Ther. 299 (2001) 620-628
16. Schwab D., Fischer H., Tabatabaei A., Poli S., and Huwyler J. Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery. J. Med. Chem. 46 (2003) 1716-1725
17. Mahar Doan K.M., Humphreys J.E., Webster L.O., Wring S.A., Shampine L.J., Serabjit-Singh C.J., Adkison K.K., and Polli J.W. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J. Pharmacol. Exp. Ther. 303 (2002) 1029-1037
18. Meier M., Blatter X.L., Seelig A., and Seelig J. Interaction of verapamil with lipid membranes and P-glycoprotein: connecting thermodynamics and membrane structure with functional activity. Biophys. J. 91 (2006) 2943-2955
19. Seelig A., Landwojtowicz E., Fischer H., and Li Blatter X. Towards P-glycoprotein structure-activity relationships. In: Waterbeemd v.d., and Lennernäs A. (Eds). Drug Bioavailability/Estimation of Solubility (2003), Permeability and Absorption, Wiley/VCH, Weinheim 461-492
20. Aanismaa P., and Seelig A. P-glycoprotein kinetics measured in plasma membrane vesicles and living cells. Biochemistry 46 (2007) 3394-3404
21. Gatlik-Landwojtowicz E., Aanismaa P., and Seelig A. Quantification and characterization of P-glycoprotein-substrate interactions. Biochemistry 45 (2006) 3020-3032
22. Li-Blatter X., Nervi P., and Seelig A. Detergents as intrinsic P-glycoprotein substrates and inhibitors. Biochim. Biophys. Acta 1788 (2009) 2335-2344
23. Cardarelli C.O., Aksentijevich I., Pastan I., and Gottesman M.M. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters. Cancer Res. 55 (1995) 1086-1091
24. Gatlik-Landwojtowicz E., Aanismaa P., and Seelig A. The rate of P-glycoprotein activation depends on the metabolic state of the cell. Biochemistry 43 (2004) 14840-14851
25. McConnell H.M., Owicki J.C., Parce J.W., Miller D.L., Baxter G.T., Wada H.G., and Pitchford S. The cytosensor microphysiometer: biological applications of silicon technology. Science 257 (1992) 1906-1912
26. Litman T., Zeuthen T., Skovsgaard T., and Stein W.D. Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity. Biochim. Biophys. Acta 1361 (1997) 159-168
27. Al-Shawi M.K., Polar M.K., Omote H., and Figler R.A. Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein. J. Biol. Chem. 278 (2003) 52629-52640
28. Fischer H. Passive Diffusion and Active Transport Through Biological Membranes-Binding of Drugs to Transmembrane Receptors (1998), Philosophisch-Naturwissenschaftlischen Fakultät, Universität Basel, Basel 170
29. Gerebtzoff G., Li-Blatter X., Fischer H., Frentzel A., and Seelig A. Halogenation of drugs enhances membrane binding and permeation. Chembiochem 5 (2004) 676-684
30. Fischer H., Gottschlich R., and Seelig A. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J. Membr. Biol. 165 (1998) 201-211
31. Gerebtzoff G., and Seelig A. In silico prediction of blood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter. J. Chem. Inf. Model. 46 (2006) 2638-2650
32. Seelig A., and Landwojtowicz E. Structure-activity relationship of P-glycoprotein substrates and modifiers. Eur. J. Pharm. Sci. 12 (2000) 31-40
33. Urbatsch I.L., and Senior A.E. Effects of lipids on ATPase activity of purified Chinese hamster P-glycoprotein. Arch. Biochem. Biophys. 316 (1995) 135-140
34. Seelig A. Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. Biochim. Biophys. Acta 899 (1987) 196-204
35. Frézard F., and Garnier-Suillerot A. Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature. Biochim. Biophys. Acta 1389 (1998) 13-22
36. Wolfenden R., and Liang Y.L. Influences of solvent on group transfer potentials and biochemical recognition of carbohydrates. Anomalous solvation of the anomeric hydroxyl group. J. Biol. Chem. 263 (1988) 8022-8026
37. Berry J.S. Structure and partition coefficient. Synthesis and properties of dodecyl methyl pentaerythrityl ethers. J. Org. Chem. 25 (1960) 1272-1274
38. Lantzch G., Binder H., Heerklotz H., Wendling M., and Klose G. Surface areas and packing constraints in POPC C (12)EO (n) membranes. A time-resolved fluorescence study. Biophys. Chem. 58 (1996) 289-302
39. Sauna Z.E., Smith M.M., Muller M., Kerr K.M., and Ambudkar S.V. The mechanism of action of multidrug-resistance-linked P-glycoprotein. J. Bioenerg. Biomembr. 33 (2001) 481-491
40. Sauna Z.E., Muller M., Peng X.H., and Ambudkar S.V. Importance of the conserved Walker B glutamate residues, 556 and 1201, for the completion of the catalytic cycle of ATP hydrolysis by human P-glycoprotein (ABCB1). Biochemistry 41 (2002) 13989-14000
41. Shukla S., Wu C.P., and Ambudkar S.V. Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges. Expert Opin. Drug Metab. Toxicol. 4 (2008) 205-223
42. Aanismaa P., Gatlik-Landwojtowicz E., and Seelig A. P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle. Biochemistry 47 (2008) 10197-10207
43. Reza M.S., Quadir M.A., and Haider S.S. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. J. Pharm. Pharm. Sci. 6 (2003) 282-291